Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
The median serum HO-1 in acute exacerbation of IPF was significantly higher than that in IIPs other than IPF and CTD-ILD (Fig
Early clinical care helps prevent scarring
In a 48-week phase II clinical trial conducted on patients with type 2 diabetes and obesity, treatment with a dose of 10 mg/kg of bimagrumab resulted in a significant reduction in fat mass by 20.5% (compared to 0.5% in the placebo group), while lean body mass increased by 3.6% (as opposed to a decrease of 0.8% in the placebo group), leading to an overall body weight reduction of -6.5%, which was substantially better than the -0.8% observed in the placebo group
Older protocols used CJC-1295 with GHRP-6 or GHRP-2, which are more potent but less selective
Long-term supplementation (10-20 g/day for 6-9 months) showed substantial benefits, with 20 g daily improving physical component scores in females (p=0.013)
